Alpha Tau Medical Ltd.

DRTSNASDAQHealthcare● Active

$9.28

$-0.07(-0.75%)

Market Cap$838224129

P/E Ratio—

52W High$11.62

52W Low$2.85

Avg Volume612K

Open$9.58

Beta1.20

Free Cash Flow Financials Revenue

Alpha Tau Medical Ltd. (DRTS) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

DRTS · free cash flow · updated Jun 9, 2026

Core FCF metrics

DRTS · FCF · TTM · margin & CAGR

Free cash flow was −$32.8M for FY2025 (fiscal year ending 2025-12-31), down 48.7% year-over-year

FY2025 Free Cash Flow−$32.8M▼ -48.7% YoY

Trailing 12M (TTM)−$32.8Mtrailing 4 quarters sum

FCF Margin——

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

DRTS · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$26.7M(6M)−$32.8M▼ 48.7%—

FY2024−$19.8M(2M)−$22.0M▲ +9.6%—

FY2023−$18.0M(6M)−$24.4M▲ +1.7%—

FY2022−$23.9M(1M)−$24.8M▼ 68.1%—

FY2021−$11.8M(3M)−$14.7M▼ 33.8%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

DRTS · P/FCF · FCF yield · FCF per share

Alpha Tau Medical Ltd. (DRTS) reported negative free cash flow of −$0.03B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

DRTS · cash flow statement · operating / investing / financing

For FY2025, Alpha Tau Medical Ltd. generated −$26.7M in operating cash flow and spent 6M in capital expenditures, yielding −$32.8M in free cash flow.

Operating Activities

−$26.7M

Cash from core business operations

2025-12-31

Investing Activities

−$20.6M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$45.8M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$26.7M) − |CapEx| (6M) = FCF (−$32.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

DRTS vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Alpha Tau Medical Ltd.YOU

DRTS

−$32.8M-48.7%—

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Alpha Tau Medical Ltd. (DRTS) reported free cash flow of −$32.8M for FY2025 (fiscal year ending 2025-12-31), down 48.7% year-over-year.

Alpha Tau Medical Ltd. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 7 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

DRTS free cash flow · 8 questions

Alpha Tau Medical Ltd. free cash flow was −$32.8M for FY2025, down 48.7% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$32.8M.

DRTS free cash flowDRTS FCFDRTS FCF 2025DRTS free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Alpha Tau Medical Ltd. · Alpha Tau Medical Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026